AG
CALA

Aperio Group’s Calithera Biosciences, Inc CALA Stock Holding History

Aperio Group’s Portfolio CALA Stock Details CALA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		$76K Buy
+777
New +$68.1K ﹤0.01% 2393
2020
Q3 		– Sell
-540
Closed -$57K – 2403
2020
Q2 		$57K Buy
+540
New +$64.1K ﹤0.01% 2297

Other funds holding CALA

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DMPV
Delphi Management Partners VIII San Mateo, California $138M AUM 56.74% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Aperio Group's CALA Position: Q4 2020 in Review

Aperio Group opened a new position in Calithera Biosciences, Inc (CALA) in Q4 2020: 777 shares worth $76K. The stake represents ﹤0.01% of the portfolio and ranks #2393 among its holdings. This is a return to the name: Aperio Group previously reported a position in CALA as recently as Q2 2020.

Aperio Group first reported a position in CALA in Q2 2020 and has held it in 2 quarters since. 105 funds tracked by Wall St. Rank hold CALA as of Q4 2020.

  • Aperio Group held 777 shares of Calithera Biosciences, Inc worth $76K as of Q4 2020.
  • Calithera Biosciences, Inc was a new Aperio Group position in Q4 2020.
  • Calithera Biosciences, Inc made up ﹤0.01% of Aperio Group's portfolio in Q4 2020, its #2393 holding.
  • Aperio Group first reported a position in Calithera Biosciences, Inc in Q2 2020 and has held it in 2 quarters since.
  • 105 funds tracked by Wall St. Rank held Calithera Biosciences, Inc as of Q4 2020.

Based on Aperio Group's 13F filing for Q4 2020, filed 5 Feb 2021.